This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

the United States’ Array BioPharma and Targacept Ltd and Danish 7TM Pharma. AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other biotech stocks with the biggest upside potential. Improving Trends for Biotech ...

Pin-hole array biochips are indispensable tools in applications such as medical diagnostics, disease prediction, clinical treatment, drug development, and food safety testing. The increasing demand ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

Mackie and colleagues present a valuable comparison of lateralized gustation in two well-studied nematodes. The evidence they present that ASEL/R lateralization exists and is achieved by different ...

The Global Equity composite fell 0.86% gross of fees in the fourth quarter, in line with the 0.89% decline of the MSCI ACWI ...

Each member of the UCSF Public Affairs team oversees a wide array of beats, serving as the first point of contact for reporters seeking experts and faculty and staff seeking public relations advice.

Nature asked the world’s largest health-research funders what they are doing to study a life stage experienced by half of humanity. Here is what some of them told us.